Ikarian Capital’s Pliant Therapeutics PLRX Stock Holding History

Ikarian Capital’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Buy	+1,000,000	New	+$1.22M	0.12%	102
2022 Q2	–	Sell	-90,805	Closed	-$636K	–	189
2022 Q1	$636K	Buy	90,805 +4,093	+5%	+$41.8K	0.08%	116
2021 Q4	$1.17M	Hold	86,712	–	–	0.17%	92
2021 Q3	$1.46M	Sell	86,712 -21,988	-20%	-$467K	0.1%	140
2021 Q2	$3.17M	Hold	108,700	–	–	0.26%	93
2021 Q1	$4.28M	Buy	+108,700	New	+$3.53M	0.14%	134

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Ikarian Capital's PLRX Position: Q2 2026 in Review

Ikarian Capital opened a new position in Pliant Therapeutics (PLRX) in Q2 2026: 1,000,000 shares worth $1.14M. The stake represents 0.12% of the portfolio and ranks #102 among its holdings. This is a return to the name: Ikarian Capital previously reported a position in PLRX as recently as Q1 2022.

Ikarian Capital first reported a position in PLRX in Q1 2021 and has held it in 6 quarters since. The position peaked at $4.28M in Q1 2021. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Ikarian Capital held 1,000,000 shares of Pliant Therapeutics worth $1.14M as of Q2 2026.
Pliant Therapeutics was a new Ikarian Capital position in Q2 2026.
Pliant Therapeutics made up 0.12% of Ikarian Capital's portfolio in Q2 2026, its #102 holding.
Ikarian Capital first reported a position in Pliant Therapeutics in Q1 2021 and has held it in 6 quarters since.
Ikarian Capital's Pliant Therapeutics position peaked at $4.28M in Q1 2021.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.